Rep. Julie Johnson Sells Off Shares of CME Group Inc. (NASDAQ:CME)

Representative Julie Johnson (D-Texas) recently sold shares of CME Group Inc. (NASDAQ:CME). In a filing disclosed on December 11th, the Representative disclosed that they had sold between $1,001 and $15,000 in CME Group stock on November 13th. The trade occurred in the Representative’s “CHASE BROKERAGE ACCOUNT (3935)” account.

Representative Julie Johnson also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Charles Schwab (NYSE:SCHW) on 11/13/2025.
• Sold $1,001 – $15,000 in shares of UnitedHealth Group (NYSE:UNH) on 11/13/2025.
• Sold $1,001 – $15,000 in shares of Cigna Group (NYSE:CI) on 11/13/2025.
• Sold $1,001 – $15,000 in shares of Xcel Energy (NASDAQ:XEL) on 11/13/2025.
• Sold $1,001 – $15,000 in shares of Capital One Financial (NYSE:COF) on 11/13/2025.
• Sold $1,001 – $15,000 in shares of Walmart (NASDAQ:WMT) on 11/13/2025.
• Sold $1,001 – $15,000 in shares of Seagate Technology (NASDAQ:STX) on 11/13/2025.
• Sold $1,001 – $15,000 in shares of Wells Fargo & Company (NYSE:WFC) on 11/13/2025.
• Sold $1,001 – $15,000 in shares of Texas Instruments (NASDAQ:TXN) on 11/13/2025.
• Sold $1,001 – $15,000 in shares of The Goldman Sachs Group (NYSE:GS) on 11/13/2025.

CME Group Stock Performance

NASDAQ:CME opened at $273.55 on Monday. The firm has a market cap of $98.64 billion, a PE ratio of 26.51, a price-to-earnings-growth ratio of 4.08 and a beta of 0.28. CME Group Inc. has a fifty-two week low of $224.62 and a fifty-two week high of $290.79. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. The business has a 50 day moving average price of $271.85 and a 200-day moving average price of $272.22.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 EPS for the quarter, beating analysts’ consensus estimates of $2.63 by $0.05. The firm had revenue of $1.54 billion for the quarter, compared to analysts’ expectations of $1.56 billion. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The company’s quarterly revenue was down 3.0% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.68 EPS. Equities research analysts predict that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 30th. Stockholders of record on Friday, December 12th will be paid a $1.25 dividend. The ex-dividend date of this dividend is Friday, December 12th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.8%. CME Group’s dividend payout ratio is 48.45%.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Webster Bank N. A. raised its position in shares of CME Group by 206.9% in the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock worth $25,000 after acquiring an additional 60 shares during the period. Caldwell Trust Co increased its holdings in shares of CME Group by 116.3% in the third quarter. Caldwell Trust Co now owns 93 shares of the financial services provider’s stock valued at $25,000 after purchasing an additional 50 shares during the last quarter. Highline Wealth Partners LLC boosted its position in shares of CME Group by 84.3% during the 2nd quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 43 shares during the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA acquired a new stake in shares of CME Group during the 3rd quarter worth approximately $27,000. Finally, Financial Consulate Inc. purchased a new stake in CME Group in the third quarter valued at $28,000. 87.75% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at CME Group

In other news, insider Timothy Francis Mccourt sold 379 shares of the firm’s stock in a transaction that occurred on Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total value of $98,475.57. Following the completion of the transaction, the insider owned 9,508 shares of the company’s stock, valued at approximately $2,470,463.64. This trade represents a 3.83% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Harold Eugene Jr. Ford sold 1,000 shares of the stock in a transaction that occurred on Monday, November 3rd. The shares were sold at an average price of $263.53, for a total transaction of $263,530.00. Following the completion of the sale, the director directly owned 1,091 shares in the company, valued at approximately $287,511.23. This represents a 47.82% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 2,147 shares of company stock worth $562,079 in the last 90 days. Insiders own 0.30% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently issued reports on CME. JPMorgan Chase & Co. lifted their price objective on shares of CME Group from $252.00 to $256.00 and gave the company an “underweight” rating in a research report on Tuesday, October 14th. Argus reduced their target price on CME Group from $308.00 to $295.00 in a research note on Friday, October 31st. Raymond James Financial decreased their price target on shares of CME Group from $309.00 to $307.00 and set an “outperform” rating for the company in a research note on Monday, October 13th. Piper Sandler boosted their price target on shares of CME Group from $296.00 to $313.00 and gave the company an “overweight” rating in a report on Thursday, November 13th. Finally, Royal Bank Of Canada raised their price objective on CME Group from $282.00 to $295.00 and gave the company a “sector perform” rating in a research report on Friday, December 5th. Eight equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $290.00.

About Representative Johnson

Julie Johnson (Democratic Party) is a member of the U.S. House, representing Texas’ 32nd Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027.

Johnson (Democratic Party) ran for election to the U.S. House to represent Texas’ 32nd Congressional District. She won in the general election on November 5, 2024.

Julie Johnson earned a B.A. in history and government from the University of Texas at Austin in 1987 and a J.D. from the University of Houston Law Center in 1991. Johnson’s career experience includes working as an attorney.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.